Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
06/2003
06/25/2003CN1112362C Preparation method of 2-thiophene ethamine
06/25/2003CN1112356C Nitromethylthiobenzene derivative as inhibitors of aldose reductase
06/25/2003CN1112354C Stereo specific prepn. of chiral 1-aryl-and 1-heteroaryl-2-substituted ethyl-2-amines
06/25/2003CN1112343C Skin lightening compositions
06/24/2003US6584266 Dicyanomethylenedihydrofuran compounds and polymer pendant groups having electron withdrawing groups and bivalent cyclic bridges
06/24/2003US6583319 Cyclic compounds having a cycloalkylene chain
06/24/2003US6583183 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
06/24/2003US6583179 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
06/24/2003US6583174 Bi-cyclic compound dissolved in a glyceride; 7-((1R,3R,6R,7R)-3-(1,1-difluoropentyl)-3-hydroxy-2-oxabicyclo(4,3,0)nonane -8-one-7-yl)heptanoic acid
06/24/2003US6583173 Useful as anticoagulants in mammals; inhibitors of factor Xa
06/24/2003CA2126337C 2-amino-1,3-propanediol compound and immunosuppressant
06/19/2003WO2003050063A2 PROCESS FOR THE SYNTHESIS OF CHIRALLY PURE β-AMINO-ALCOHOLS
06/19/2003WO2003050062A2 PRODUCTION OF CHIRALLY PURE α-AMINO ACIDS ADN N-SULFONYL α-AMINO ACIDS
06/19/2003WO2003049698A2 Substituted hydrazones as inhibitors of cyclooxygenase-2
06/19/2003US20030114710 Optical information recording medium and novel immonium compound
06/19/2003US20030114521 Oxamic acids and derivatives as thyroid receptor ligands
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114499 Antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias, atrial fibrillation (AF) or atrial flutter; potassium channel modulators, beta-blocker
06/19/2003US20030114462 Drug abruse, alcoholism; respiratory system disorders, cardiovascular disorders
06/19/2003US20030114454 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/19/2003US20030114447 Controlling apoptosis; central nervous system disorders
06/19/2003US20030114441 Heterocyclic anti-epileptogenic agents and methods of use thereof
06/19/2003US20030114440 Compositions and methods of treatment for conditions responsive to testosterone elevation
06/19/2003US20030114435 Benzoic acid derivatives, processes for producing the same and drugs containing the same as the active ingredient
06/19/2003US20030113658 Contains fluoroalkyl groups; for use in a chemically amplified radiation-sensitive resin mixture, gives high transparency, no bioaccumulation, high acidity of produced acid, high boiling point, short diffusion length
06/19/2003US20030111956 Hexasubstituted benzene compounds are useful as hole transporting, green-light-emitting molecules with high glass transition temperature
06/19/2003US20030110577 Novel p-aminophenols and colorants containing said compounds
06/19/2003CA2470111A1 Production of chirally pure .alpha.-amino acids and n-sulfonyl .alpha.-amino acids
06/19/2003CA2469709A1 Substituted hydrazones as inhibitors of cyclooxygenase-2
06/19/2003CA2469021A1 Process for the synthesis of chirally pure .beta.-amino-alcohols
06/18/2003EP1318979A1 Cyclopentane derivatives as therapeutic agents
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
06/18/2003EP1318974A2 Resorcinol derivatives
06/18/2003EP1255757B1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
06/18/2003EP1098874B1 Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
06/18/2003EP0819125B1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
06/18/2003CN1425018A Novel chromophores for polymeric thin films and optical waveguide and devices comprising the same
06/18/2003CN1425012A Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme IKK-2
06/18/2003CN1111520C Matrix metalloprotease inhibitors
06/17/2003US6579987 Diaryl-enynes
06/17/2003US6579890 Matrix metalloprotease inhibitors
06/12/2003WO2003048158A1 Glycinamides as factor xa inhibitors
06/12/2003WO2003048151A1 Method for preparing chiral amines
06/12/2003WO2003048144A2 Method for monosulphonylation of an aminobenzofuran compound
06/12/2003WO2003048121A1 Therapeutic benzamide derivatives
06/12/2003WO2003048118A1 5-ht7 receptor antagonists
06/12/2003WO2003048109A1 Novel glucagon antagonists
06/12/2003WO2003048081A2 Glycinamides as factor xa inhibitors
06/12/2003WO2003047575A1 Therapeutic benzamide derivatives
06/12/2003WO2003047568A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003WO2003033503A3 Method for producing, via organometallic compounds, organic intermediate products
06/12/2003US20030109718 Enantioselective transformation of alpha, beta-unsaturated aldehydes using chiral organic catalysts
06/12/2003US20030109570 Activate a peroxisome proliferator-activated receptor (PPAR) alpha or gamma which is an intranuclear transcription factor. The compound may be used as an active ingredient to give a drug for preventing or treating a variety of diseases
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109547 Amidinophenylpyruvic acid derivatives
06/12/2003US20030109533 New benzenesulphonamide compounds
06/12/2003US20030109528 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/12/2003US20030109500 Compositions and methods for use in targeting vascular destruction
06/12/2003US20030107027 Second order nonlinear optical chromophores and electro-optic devices therefrom
06/12/2003CA2468967A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003CA2437251A1 Method for preparing chiral amines
06/11/2003EP1318149A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing them
06/11/2003EP1318140A1 Novel amide derivatives and medicinal use thereof ugs
06/11/2003EP1317431A2 Polyarylcarboxamides useful as lipid lowering agents
06/11/2003EP1317426A1 Beta-thio-amino acids
06/11/2003EP1317425A2 Resorcinol derivatives
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/11/2003EP1317413A1 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
06/11/2003EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
06/11/2003EP0996614B1 Acrylonitrile compounds, process for their production and pesticides containing them
06/11/2003EP0611301B1 Chelator compositions comprising oxime compounds
06/11/2003CN1423649A Sulfonyl oxazole amines and their use as 5-HT6 receptor ligand
06/11/2003CN1423645A 维他命d类似物 Vitamin d analogues
06/11/2003CN1423637A Novel substituted tricyclic compounds
06/11/2003CN1423627A 维生素d类似物 Vitamin d analogues
06/10/2003US6576684 Ammonium, phosphonium or sulfonium containing oligomers or polymers; controlled molecular weight, low polydispersity and a vinyl or dienyl end group; polymeric precursors and addi-tives
06/10/2003US6576614 Administering methyl ketones or closed hemiketal derivatives of aspartic acid
06/10/2003US6576596 Substituted 2-benzoyl-cyclohexan-1,3-diones with herbicidal effect
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/05/2003WO2003046200A2 Methods for ligand discovery
06/05/2003WO2003045964A1 Metallocene compounds and process for the preparation of propylene polymers
06/05/2003WO2003045957A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
06/05/2003WO2003045903A1 Hydroxyethylene compounds with asp2 inhibitory activity
06/05/2003WO2003045878A2 2,w-diaminocarboxylic acid compounds
06/05/2003WO2003045393A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
06/05/2003WO2002048124A3 Piperazine derivatives
06/05/2003US20030105161 Analgesics; antiinflamamtory agents
06/05/2003US20030105155 Prostanoic acid derivatives as agents for lowering intraocular pressure
06/05/2003US20030105148 Selective estrogen receptor modulators
06/05/2003US20030105143 Bactericides, antiseptics, cosmetics, cleaning compounds, enhaned oil recovery, papermaking
06/05/2003US20030105142 Amide derivatives useful as inhibitors of the production of cytokines
06/05/2003US20030105107 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
06/05/2003US20030105100 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/05/2003US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
06/05/2003US20030105062 Anti-bacterial agents based upon oxoanion binding
06/05/2003US20030102458 Birefringement film
06/05/2003US20030102252 Method for desulphurizing thiopene derivatives contained in fuels
06/05/2003CA2812024A1 Methods for ligand discovery